The Global Organ-on-Chip Market is Predict to reach $815.6 Million by 2028, at a CAGR of 30.2%

Published Date: 24-Nov-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Organ-on-Chip Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Organ-on-Chip Market size is expected to reach $815.6 million by 2028, rising at a market growth of 30.2% CAGR during the forecast period.

The Heart on chip market is exhibiting a CAGR of 29.9% during (2022 - 2028). Replicating in vivo cardiac tissue settings has proven difficult in the past due to problems in simulating contractility and electrical responses. Such characteristics would significantly improve the precision of in vitro experiments. In vitro investigations on cardiomyocytes that generate the electrical signals that control heartbeat, have previously benefited from microfluidics.

The North America market dominated the Global Lung on chip Market by Region in 2021; thereby, achieving a market value of $94.9 Million by 2028. The Europe market is poised to grow at a CAGR of 28.6% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 30.2% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/organ-on-chip-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AxoSim, Inc., Visikol, Inc., CN Bio Innovations Limited., Elveflow (Elvesys Group), Emulate, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc. and TARA Biosystems, Inc.

Global Organ-on-Chip Market Segmentation

By Type

  • Lung on chip
  • Heart on chip
  • Human on chip
  • Kidney on chip
  • Liver on chip
  • Intestine on chip

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • AxoSim, Inc.
  • Visikol, Inc.
  • CN Bio Innovations Limited.
  • Elveflow (Elvesys Group)
  • Emulate, Inc.
  • Insphero AG,
  • Mimetas B.V.
  • Nortis Inc.
  • Organovo Holdings, Inc.
  • TARA Biosystems, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Organ-on-Chip Market Future Scope & Opportunities 2022-2028

Europe Organ-on-Chip Market Size & Growth Forecast 2022-2028

Asia Pacific Organ-on-Chip Market Size, Share & Industry Outlook to 2028

LAMEA Organ-on-Chip Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.